Leukemia stem cells made visible to the immune system
A new study may provide the basis for combating malignant leukemia stem cells.
List view / Grid view
A new study may provide the basis for combating malignant leukemia stem cells.
A new study shows that the activity of p38 is important in MSCs, which can localise around blood vessels.
Stem cell stimulation shows promise as a potential noninvasive stroke treatment.
A new 'optochemogenetics' research approach from scientists at the Emory University School of Medicine could aid in helping stroke victims.
Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.
The FDA has released a statement on US Stem Cell Clinic LLC and US Stem Cell Inc's permanent injunction.
New study finds a combination of antibodies that can prepare mice to accept stem cells from an immunologically mismatched donor.
This article outlines the exciting developments that are taking place with immunotherapies and demonstrates how stem-cell technologies are proliferating the paradigm shift in how we tackle cancer treatment.
Thanks to new developments with induced pluripotent stem cells enabling generation of human neurons, scientists can more precisely analyse the effects that chemicals have on human cells. This article describes research into the effects of cannabis on neuronal development and implications of its legalisation in Canada.
Researchers have, for the first time, duplicated a patient's blood-brain barrier (BBB), creating a human BBB chip with stem cells.
A new study shows promise for future neural stem cell therapies in replacing cells lost through disease or injury.
Sartorius Cubis® II is designed to follow US FDA data integrity principles that require data to be accurate, legible, contemporaneous, original and attributable.
This in-depth focus looks at the modification of stem cells to facilitate their efficient delivery to tumours, highlighting the new development of pluripotent stem cells.
In this issue: novel approaches to produce radiolabelled antibodies, the use of CRISPR/Cas9 to accelerate the development of targeted therapies and utilisation of stem cells to study the effects of cannabis on neuronal development.